Literature DB >> 16153751

A review of vaccine research and development: tuberculosis.

Marc P Girard1, Uli Fruth, Marie-Paule Kieny.   

Abstract

Substantial progress has been made during the past 15 years towards the development of improved vaccines for tuberculosis. This is due to advances in the characterization of genes and antigens of Mycobacterium tuberculosis (M. tb), aided by the availability of genome sequences of different mycobacterial species and M. tb isolates and to greater understanding of protective immune responses to the pathogen in both animals and humans. More than one hundred candidate vaccines have been tested in animal models, representing all of the major vaccine design strategies, and some have now moved into clinical trials. This review summarizes recent advances in tuberculosis vaccine development.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16153751     DOI： 10.1016/j.vaccine.2005.07.045

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  8 in total

1.  A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice.

Authors:  Shen-An Hwang; Katarzyna Wilk; Marian L Kruzel; Jeffrey K Actor
Journal:  Vaccine       Date:  2009-04-05       Impact factor: 3.641

2.  Design and Construction of a Cloning Vector Containing the hspX Gene of Mycobacterium tuberculosis.

Authors:  Atieh Yaghoubi; Ehsan Aryan; Hosna Zare; Shadi Alami; Roghayeh Teimourpour; Zahra Meshkat
Journal:  Rep Biochem Mol Biol       Date:  2016-10

3.  Analysis of the secretome and identification of novel constituents from culture filtrate of bacillus Calmette-Guerin using high-resolution mass spectrometry.

Authors:  Jianhua Zheng; Xianwen Ren; Candong Wei; Jian Yang; Yongfeng Hu; Liguo Liu; Xingye Xu; Jin Wang; Qi Jin
Journal:  Mol Cell Proteomics       Date:  2013-04-24       Impact factor: 5.911

4.  Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates.

Authors:  Michelle H Larsen; Karolin Biermann; Bing Chen; Tsungda Hsu; Vasan K Sambandamurthy; Andrew A Lackner; Pyone Pyone Aye; Peter Didier; Dan Huang; Linyun Shao; Huiyong Wei; Norman L Letvin; Richard Frothingham; Barton F Haynes; Zheng W Chen; William R Jacobs
Journal:  Vaccine       Date:  2009-06-02       Impact factor: 3.641

5.  The TB-specific CD4(+) T cell immune repertoire in both cynomolgus and rhesus macaques largely overlap with humans.

Authors:  Bianca R Mothé; Cecilia S Lindestam Arlehamn; Courtney Dow; Myles B C Dillon; Roger W Wiseman; Patrick Bohn; Julie Karl; Nadia A Golden; Trey Gilpin; Taylor W Foreman; Mark A Rodgers; Smriti Mehra; Thomas J Scriba; JoAnne L Flynn; Deepak Kaushal; David H O'Connor; Alessandro Sette
Journal:  Tuberculosis (Edinb)       Date:  2015-08-28       Impact factor: 3.131

6.  Transgenic carrot expressing fusion protein comprising M. tuberculosis antigens induces immune response in mice.

Authors:  Natalia V Permyakova; Alla A Zagorskaya; Pavel A Belavin; Elena A Uvarova; Olesya V Nosareva; Andrey E Nesterov; Anna A Novikovskaya; Evgeniy L Zav'yalov; Mikhail P Moshkin; Elena V Deineko
Journal:  Biomed Res Int       Date:  2015-04-09       Impact factor: 3.411

Review 7.  Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines.

Authors:  Luis O De Serrano; David J Burkhart
Journal:  J Nanobiotechnology       Date:  2017-11-17       Impact factor: 10.435

Review 8.  Vaccine research and development: tuberculosis as a global health threat.

Authors:  Mohammed Maikudi Usman; Salmah Ismail; Teow Chong Teoh
Journal:  Cent Eur J Immunol       Date:  2017-08-08       Impact factor: 2.085
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.